MedPath

Invitro Maturation of Oocytes for Patients With Polycystic Ovaries

Not Applicable
Conditions
Infertility
Polycystic Ovaries
Registration Number
NCT00631982
Lead Sponsor
Assaf-Harofeh Medical Center
Brief Summary

In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Polycystic ovaries
  • Needing IVF for fertility treatment
Exclusion Criteria
  • Age above 39

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
maturation rate,18 months
Secondary Outcome Measures
NameTimeMethod
Fertilization rate, pregnancy rate18 months

Trial Locations

Locations (1)

IVF and Infertility Unit, Assaf Harofeh Medical Center

🇮🇱

Zerifin, Israel

IVF and Infertility Unit, Assaf Harofeh Medical Center
🇮🇱Zerifin, Israel
Raphael Ron-El, MD
Contact
+972-8-9779005
Raphael Ron - El, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.